Cerity Partners OCIO’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | $5.82M | Buy |
15,907
+1,171
| +8% | +$415K | 0.19% | 79 |
|
|
2022
Q3 | $4.76M | Buy |
14,736
+2,555
| +21% | +$810K | 0.17% | 83 |
|
|
2022
Q2 | $3.95M | Buy |
12,181
+2,903
| +31% | +$871K | 0.13% | 94 |
|
|
2022
Q1 | $2.66M | Sell |
9,278
-3,484
| -27% | -$897K | 0.08% | 121 |
|
|
2021
Q4 | $3.52M | Buy |
12,762
+382
| +3% | +$96.8K | 0.1% | 104 |
|
|
2021
Q3 | $2.86M | Buy |
12,380
+591
| +5% | +$146K | 0.09% | 105 |
|
|
2021
Q2 | $2.71M | Buy |
11,789
+251
| +2% | +$50.4K | 0.09% | 111 |
|
|
2021
Q1 | $2.15M | Buy |
11,538
+743
| +7% | +$145K | 0.08% | 116 |
|
|
2020
Q4 | $1.82M | Buy |
10,795
+514
| +5% | +$76.7K | 0.07% | 120 |
|
|
2020
Q3 | $1.52M | Buy |
10,281
+395
| +4% | +$61.1K | 0.07% | 127 |
|
|
2020
Q2 | $1.62M | Buy |
9,886
+1,144
| +13% | +$176K | 0.08% | 122 |
|
|
2020
Q1 | $1.21M | Sell |
8,742
-113
| -1% | -$15.5K | 0.07% | 118 |
|
|
2019
Q4 | $1.3M | Buy |
8,855
+855
| +11% | +$99.1K | 0.06% | 126 |
|
|
2019
Q3 | $895K | Buy |
8,000
+185
| +2% | +$20.6K | 0.05% | 165 |
|
|
2019
Q2 | $866K | Buy |
7,815
+4,539
| +139% | +$535K | 0.05% | 159 |
|
|
2019
Q1 | $425K | Sell |
3,276
-224
| -6% | -$27.2K | 0.02% | 215 |
|
|
2018
Q4 | $405K | Sell |
3,500
-46
| -1% | -$5.14K | 0.03% | 233 |
|
|
2018
Q3 | $381K | Buy |
3,546
+179
| +5% | +$17.9K | 0.02% | 222 |
|
|
2018
Q2 | $287K | Sell |
3,367
-92
| -3% | -$7.56K | 0.02% | 230 |
|
|
2018
Q1 | $268K | Buy |
3,459
+76
| +2% | +$6.12K | 0.02% | 235 |
|
|
2017
Q4 | $286K | Buy |
3,383
+101
| +3% | +$8.59K | 0.02% | 235 |
|
|
2017
Q3 | $281K | Buy |
3,282
+81
| +3% | +$6.64K | 0.02% | 215 |
|
|
2017
Q2 | $263K | Buy |
3,201
+766
| +31% | +$62.5K | 0.02% | 224 |
|
|
2017
Q1 | $205K | Buy |
+2,435
| New | +$195K | 0.02% | 231 |
|
|
2016
Q1 | – | Sell |
-2,452
| Closed | -$207K | – | 224 |
|
|
2015
Q4 | $207K | Sell |
2,452
-38
| -2% | -$3.15K | 0.02% | 204 |
|
|
2015
Q3 | $208K | Buy |
2,490
+59
| +2% | +$4.98K | 0.02% | 211 |
|
|
2015
Q2 | $203K | Sell |
2,431
-863
| -26% | -$65.8K | 0.02% | 209 |
|
|
2015
Q1 | $239K | Sell |
3,294
-9,499
| -74% | -$676K | 0.03% | 196 |
|
|
2014
Q4 | $883K | Buy |
12,793
+1,130
| +10% | +$76.3K | 0.11% | 77 |
|
|
2014
Q3 | $756K | Buy |
11,663
+2,020
| +21% | +$128K | 0.1% | 76 |
|
|
2014
Q2 | $599K | Buy |
9,643
+764
| +9% | +$45.6K | 0.08% | 81 |
|
|
2014
Q1 | $523K | Buy |
8,879
+3,137
| +55% | +$175K | 0.08% | 86 |
|
|
2013
Q4 | $293K | Buy |
5,742
+1,467
| +34% | +$73.5K | 0.05% | 122 |
|
|
2013
Q3 | $215K | Buy |
+4,275
| New | +$224K | 0.04% | 140 |
|
Other funds holding LLY
Cerity Partners OCIO's LLY Position: Q4 2022 in Review
Cerity Partners OCIO increased its Eli Lilly (LLY) stake by 7.9% in Q4 2022, buying an estimated $415K and bringing the position to 15,907 shares worth $5.82M. The position accounts for 0.19% of the portfolio, ranked #79.
Cerity Partners OCIO first reported a position in LLY in Q3 2013 and has held it in 34 quarters since. 2,671 funds tracked by Wall St. Rank hold LLY as of Q4 2022.
- Cerity Partners OCIO held 15,907 shares of Eli Lilly worth $5.82M as of Q4 2022.
- Cerity Partners OCIO bought 1,171 Eli Lilly shares in Q4 2022, an estimated $415K.
- Eli Lilly made up 0.19% of Cerity Partners OCIO's portfolio in Q4 2022, its #79 holding.
- Cerity Partners OCIO first reported a position in Eli Lilly in Q3 2013 and has held it in 34 quarters since.
- 2,671 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2022.
Based on Cerity Partners OCIO's 13F filing for Q4 2022, filed 2 Feb 2023.